Join our community of smart investors

Consort Medical: a long shot

The manufacturer is ready for the future of medicine with its array of novel drug dispensing devices
Consort Medical: a long shot

Traditional ingredients used in medicines are small, artificially manufactured chemicals which are relatively easy to replicate in big batches. Modern drugs are increasingly made up of much larger, live biological particles which require specialised delivery mechanisms and manufacturing. This is good news for Consort Medical (CSRT). The group has developed a novel range of auto-injectors which can be used for these highly complex medicines. Although launch isn’t expected until 2020, analysts have high hopes for the devices.  

IC TIP: Buy at 1157p

To continue reading...
Join our Community of Smart Investors
  • Independent full-length company analysis
  • Actionable investment ideas and recommendations
  • Expert investment tools and data
  • Stock screens from Algy Hall
Have an account? Sign in